Afternoon comment: the three major indexes rose slightly in half a day, and the concept of Shanghai's state-owned enterprise reform lifted the tide of daily limit. The three major indexes opened lower and went higher in early trading and rose slightly in half a day. In terms of sectors, the concept of Shanghai's state-owned enterprise reform is on the rise, and Shanghai Material Trade, First Medicine and Shibei High-tech are collectively on the rise. The retail sector continued to be strong, with the daily limit of Youa, Zhongbai Group and Maoye Commercial. The concept of AI glasses is higher, and Tianjian shares and Star Technology both have a daily limit of 20cm; Insurance stocks continued to adjust, and Tianmao Group fell to an intraday limit; Sora concept stocks collectively adjusted back, and the word Huayang Lianzhong fell; Bank shares fluctuated lower, with Bank of Ningbo leading the decline. Overall, stocks rose more and fell less, with more than 3,500 stocks rising. On the disk, Shanghai's state-owned enterprise reform, AI glasses and retail sectors were among the top gainers, while insurance, Sora concept and banking sectors were among the top losers.Spot silver fell 1% in the day and is now reported at $31.57 per ounce.Vietnam Customs: The export volume of rice in November was 704,608 tons.
Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.Five members of South Korea's ruling party supported the impeachment of Yin Xiyue. Kim Jae-sub, a member of South Korea's ruling National Power Party, announced through live television that he would no longer abide by the ruling party's position of opposing the impeachment of President Yin Xiyue and would vote in favor of the next presidential impeachment case. At present, five members of South Korea's ruling party have indicated that they will support the impeachment of President Yin Xiyue. There are 300 seats in South Korea's National Assembly, and the impeachment case of the President must obtain at least 2/3, that is, at least 200 members vote in favor before it can pass the National Assembly and enter the trial stage of the Korean Constitutional Court. At present, South Korea's parliament, including the largest opposition party, the Common Democratic Party, has 192 seats in the opposition camp and 108 seats in the ruling party. On the premise that all members of the opposition camp voted for impeachment, only eight members of the ruling party voted for it, and Yin Xiyue's impeachment case will pass the parliament. At present, three members of parliament from the ruling party need to vote for impeachment. (CCTV International News)Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
According to the monetary authority of singapore survey, economists predict that the core inflation rate will be 1.8% in 2025.According to the survey of Monetary Authority of Singapore, 33% people expect that the slope of Singapore's exchange rate will be lowered in the January monetary policy evaluation (previously 50%).Treasury futures closed in early trading, with the main contract of 2-year Treasury futures (TS) falling by 0.06%, 5-year Treasury futures (TF) falling by 0.13%, 10-year Treasury futures (T) falling by 0.15% and 30-year Treasury futures (TL) falling by 0.26%.
Strategy guide
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14